Reversible ventricular arrythmia induced by dasatinib

Spechbach, Hervé; Morel, Philippe; Ing Lorenzini, Kuntheavy; Besson, Marie; Getaz, Laurent; Sunthorn, Henri; Chalandon, Yves

doi:10.1002/ccr3.5

Scientific article

Case report

Open access

English

Reversible ventricular arrythmia induced by dasatinib

ContributorsSpechbach, Hervé; Morel, Philippe; Ing Lorenzini, Kuntheavy

; Besson, Marie; Getaz, Laurent; Sunthorn, Henri; Chalandon, Yves

Published inClinical case reports, vol. 1, no. 1, p. 20-25

Publication date2013

Abstract

Ventricular arrhythmias induced by dasatinib are rare events, but physicians in charge of chronic myeloid leukemia patients should be aware of such potential complications and the need for regular ECG controls during treatment with tyrosine kinase inhibitors.

Affiliation

Research group

Citation (ISO format)

SPECHBACH, Hervé et al. Reversible ventricular arrythmia induced by dasatinib. In: Clinical case reports, 2013, vol. 1, n° 1, p. 20–25. doi: 10.1002/ccr3.5

Article (Published version)

Identifiers

PID : unige:55997
DOI : 10.1002/ccr3.5
PMID : 25356203

ISSN of the journal2050-0904

580views

172downloads

Creation05/01/2015 1:10:00 PM

First validation05/01/2015 1:10:00 PM

Update time03/14/2023 11:15:10 PM

Status update03/14/2023 11:15:10 PM

Last indexation01/16/2024 5:55:15 PM

Archive ouverte UNIGE

Reversible ventricular arrythmia induced by dasatinib

Ventricular arrhythmias induced by dasatinib are rare events, but physicians in charge of chronic myeloid leukemia patients should be aware of such potential complications and the need for regular ECG controls during treatment with tyrosine kinase inhibitors.

Technical informations